Spots Global Cancer Trial Database for esophagogastric junction adenocarcinoma
Every month we try and update this database with for esophagogastric junction adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Clinical Outcomes of Robotic Versus Laparoscopic Assisted Radical Gastrectomy for Advanced Siewert II/III AEG | NCT04153058 | Esophagogastric... | Robotic Assiste... Laparoscopic As... | 18 Years - 75 Years | Fujian Medical University | |
| Chemotherapy Sequential Tislelizumab After Radical Resection in Patients With dMMR/MSI-H or POLE/POLD1 Mutations | NCT06118658 | Gastric Colorectal Aden... | tislelizumab | 18 Years - 75 Years | China Medical University, China | |
| Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma | NCT05970627 | Adenocarcinoma ... Adenocarcinoma ... Epstein-Barr Vi... | Toripalimab Oxaliplatin S1 | 18 Years - 80 Years | First Affiliated Hospital of Zhejiang University | |
| Study of FMT Combined With Nivolumab in Gastric Cancer | NCT05001360 | Gastric Adenoca... Esophagogastric... Esophagus Adeno... | XBI-302 + Nivol... | 18 Years - 70 Years | Fujian Cancer Hospital | |
| A Prospective Clinical Study of Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Ⅱ AEG | NCT04423354 | Esophagogastric... Siewert Type II... | Transthoracic S... | 18 Years - 78 Years | Guangdong Provincial Hospital of Traditional Chinese Medicine | |
| Cadonilimab+ Paclitaxel (Albumin-bound) Treat Advanced Gastric Adenocarcinoma With PD-(L)1 Inhibitors Resistance | NCT06118645 | Gastric Adenoca... | cadonilimab com... | 18 Years - 75 Years | China Medical University, China | |
| Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma | NCT05170503 | Esophagogastric... | Sintilimab | 18 Years - 75 Years | Sun Yat-sen University | |
| Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma | NCT05170503 | Esophagogastric... | Sintilimab | 18 Years - 75 Years | Sun Yat-sen University | |
| Cadonilimab+ Paclitaxel (Albumin-bound) Treat Advanced Gastric Adenocarcinoma With PD-(L)1 Inhibitors Resistance | NCT06118645 | Gastric Adenoca... | cadonilimab com... | 18 Years - 75 Years | China Medical University, China | |
| Chemotherapy Sequential Tislelizumab After Radical Resection in Patients With dMMR/MSI-H or POLE/POLD1 Mutations | NCT06118658 | Gastric Colorectal Aden... | tislelizumab | 18 Years - 75 Years | China Medical University, China | |
| Clinical Outcomes of Robotic Versus Laparoscopic Assisted Radical Gastrectomy for Advanced Siewert II/III AEG | NCT04153058 | Esophagogastric... | Robotic Assiste... Laparoscopic As... | 18 Years - 75 Years | Fujian Medical University | |
| Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma | NCT05715931 | Adenocarcinoma ... Adenocarcinoma ... HER2-positive G... | Toripalimab Trastuzumab 5-FU, leucovori... | 18 Years - 80 Years | First Affiliated Hospital of Zhejiang University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
